Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
The Journal of Clinical Investigation
|
February 24, 2007
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Amy M Avila, Barrington G Burnett, Addis A Taye, et al.
Plos Genetics
|
January 22, 2010
Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology
Astrid C Haugen, Nicholas A Di Prospero, Joel S Parker, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
November 20, 2014
Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants
Damayanthi Devineni, Nicole Vaccaro, Joe Murphy, et al.
Alimentary Pharmacology & Therapeutics
|
March 15, 2023
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials
Juan M Pericàs, Nicholas A Di Prospero, Quentin M Anstee, et al.
Brain : a Journal of Neurology
|
October 23, 2009
Clinical features of spinal and bulbar muscular atrophy
Lindsay E Rhodes, Brandi K Freeman, Sungyoung Auh, et al.
Rehabilitation Research and Practice
|
May 31, 2014
Assessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool
Michael O Harris-Love, Lindsay Fernandez-Rhodes, Galen Joe, et al.
The Lancet. Neurology
|
January 11, 2011
Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial
Lindsay E Fernández-Rhodes, Angela D Kokkinis, Michelle J White, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
The Journal of Clinical Investigation
|
February 24, 2007
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Amy M Avila, Barrington G Burnett, Addis A Taye, et al.
Plos Genetics
|
January 22, 2010
Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology
Astrid C Haugen, Nicholas A Di Prospero, Joel S Parker, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
November 20, 2014
Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants
Damayanthi Devineni, Nicole Vaccaro, Joe Murphy, et al.
Alimentary Pharmacology & Therapeutics
|
March 15, 2023
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials
Juan M Pericàs, Nicholas A Di Prospero, Quentin M Anstee, et al.
Brain : a Journal of Neurology
|
October 23, 2009
Clinical features of spinal and bulbar muscular atrophy
Lindsay E Rhodes, Brandi K Freeman, Sungyoung Auh, et al.
Rehabilitation Research and Practice
|
May 31, 2014
Assessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool
Michael O Harris-Love, Lindsay Fernandez-Rhodes, Galen Joe, et al.
The Lancet. Neurology
|
January 11, 2011
Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial
Lindsay E Fernández-Rhodes, Angela D Kokkinis, Michelle J White, et al.
Page
of 3